Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation
JCI Insight · 2024
DOI: 10.1172/jci.insight.174133 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Nathan Gf Leborgne und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology and Immunology, Mittelhäusern, Switzerland. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Studies on severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) have highlighted the crucial role of host proteases for viral replication and the immune response. The serine proteases furin and TMPRSS2 and lysosomal cysteine proteases facilitate viral entry by limited proteolytic processing of the spike (S) protein. While neutrophils are recruited to the lungs during COVID-19 pneumonia, little is known about the role of the neutrophil serine proteases (NSPs) cathepsin G (CatG), elastase (NE), and proteinase 3 (PR3) on SARS-CoV-2 entry and replication. Furthermore, the current paradigm is that NSPs may contribute to the pathogenesis of severe COVID-19. Here, we show that these proteases cleaved the S protein at multiple sites and abrogated viral entry and replication in vitro. In mouse models, CatG significantly inhibited viral replication in the lung. Importantly, lung inflammation and pathology were increased in mice deficient in NE and/or CatG. These results reveal that NSPs contribute to innate defenses against SARS-CoV-2 infection via proteolytic inactivation of the S protein and that NE and CatG limit lung inflammation in vivo. We conclude that therapeutic interventions aiming to reduce the activity of NSPs may interfere with viral clearance and inflammation in COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Virology and Immunology, Mittelhäusern, Switzerland.
- Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty.
- Graduate School for Cellular and Biomedical Sciences.
- COMPATH, Institute of Animal Pathology, Vetsuisse Faculty.
- Division of Neurological Sciences, Vetsuisse Faculty, and.
- Multidisciplinary Center for Infectious Diseases (MCID), University of Bern, Bern, Switzerland.
Förderung
- Swiss National Science Foundation
Zitieren
APA
Leborgne, N. G., Devisme, C., Kozarac, N., Berenguer Veiga, I., Ebert, N., Godel, A., Grau-Roma, L., Scherer, M., Plattet, P., Thiel, V., Zimmer, G., Taddeo, A., & Benarafa, C. (2024). Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation. JCI Insight. https://doi.org/10.1172/jci.insight.174133
Vancouver
Leborgne NG, Devisme C, Kozarac N, Berenguer Veiga I, Ebert N, Godel A, et al. Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation. JCI Insight. 2024. doi:10.1172/jci.insight.174133
BibTeX
@article{Leborgne2024,
author = {Leborgne, Nathan Gf and Devisme, Christelle and Kozarac, Nedim and Berenguer Veiga, Inês and Ebert, Nadine and Godel, Aurélie and Grau-Roma, Llorenç and Scherer, Melanie and Plattet, Philippe and Thiel, Volker and Zimmer, Gert and Taddeo, Adriano and Benarafa, Charaf},
title = {Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation},
journal = {JCI Insight},
year = {2024},
doi = {10.1172/jci.insight.174133}
}
EUVIMED